Exparel liposomal Unjoni Ewropea - Malti - EMA (European Medicines Agency)

exparel liposomal

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Zynrelef Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zynrelef

heron therapeutics, b.v. - bupivacaine, meloxicam - uġigħ, wara l-operazzjoni - anestetiċi - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.

Lojuxta Unjoni Ewropea - Malti - EMA (European Medicines Agency)

lojuxta

amryt pharmaceuticals dac - lomitapide - iperkolesterolemija - aġenti li jimmodifikaw il-lipidi - lojuxta huwa indikat bħala frozen dieta low‑fat u lipid‑lowering prodotti mediċinali oħra jew mingħajru baxxa density-lipoprotein (ldl) aferesi fil-pazjenti adulti ma hypercholesterolaemia homozygous familjari (hofh). Ġenetiċi-konferma tal-hofh għandu jinkiseb kull meta jkun possibbli. - forom l-oħra tal-primarja hyperlipoproteinaemia u l-kawżi sekondarji ta ' l-iperkolesterolimja (e. sindromu nefrotiku, ipotirojdiżmu) għandhom jiġu esklużi.

Prialt Unjoni Ewropea - Malti - EMA (European Medicines Agency)

prialt

esteve pharmaceuticals gmbh - ziconotide - injections, spinal; pain - analġeżiċi - ziconotide huwa indikat għall-kura ta 'uġigħ sever u kroniku f'pazjenti li jeħtieġu analġeżija intrateġika (it).